Today's weakness in DaVita (DVA -1.7%) shares perhaps is attributable to a NY Times article...


Today's weakness in DaVita (DVA -1.7%) shares perhaps is attributable to a NY Times article describing how a shift by the U.S. government in how it pays for drugs to treat dialysis patients may have resulted in a jump in blood transfusions for patients who now may not be getting enough of the medications.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs